<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Vet Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Vet. Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JVMS</journal-id>
      <journal-title-group>
        <journal-title>The Journal of Veterinary Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0916-7250</issn>
      <issn pub-type="epub">1347-7439</issn>
      <publisher>
        <publisher-name>The Japanese Society of Veterinary Science</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26616155</article-id>
      <article-id pub-id-type="pmc">4829524</article-id>
      <article-id pub-id-type="publisher-id">15-0425</article-id>
      <article-id pub-id-type="doi">10.1292/jvms.15-0425</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Clinical Pathology</subject>
          <subj-group>
            <subject>Note</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A case report of suspected hepatopulmonary syndrome secondary to ductal plate
malformation with chronic active hepatitis in a dog</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>KANEKO</surname>
            <given-names>Yasuyuki</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>TORISU</surname>
            <given-names>Shidow</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref rid="cor1" ref-type="corresp">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>HAGIO</surname>
            <given-names>Mitsuyoshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>YAMAGUCHI</surname>
            <given-names>Ryoji</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>MIZUTANI</surname>
            <given-names>Shinya</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>NAGANOBU</surname>
            <given-names>Kiyokazu</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1)</label>Veterinary Teaching Hospital, Faculty of Agriculture,
University of Miyazaki, 1&#x2013;1 Gakuen Kibanadai-nishi, Miyazaki 889&#x2013;2192, Japan</aff>
        <aff id="aff2"><label>2)</label>Laboratory of Veterinary Surgery, Faculty of Agriculture,
University of Miyazaki, 1&#x2013;1 Gakuen Kibanadai-nishi, Miyazaki 889&#x2013;2192, Japan</aff>
        <aff id="aff3"><label>3)</label>Department of Veterinary Pathology, Faculty of Agriculture,
University of Miyazaki, 1&#x2013;1 Gakuen Kibanadai-nishi, Miyazaki 889&#x2013;2192, Japan</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>*</label>Correspondence to: Torisu, T., Veterinary Teaching
Hospital, Faculty of Agriculture, University of Miyazaki, 1&#x2013;1 Gakuen Kibanadai-nishi,
Miyazaki 889&#x2013;2192, Japan. e-mail: <email xlink:href="torisu@cc.miyazaki-u.ac.jp">torisu@cc.miyazaki-u.ac.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <volume>78</volume>
      <issue>3</issue>
      <fpage>493</fpage>
      <lpage>497</lpage>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>7</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>10</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2016 The Japanese Society of Veterinary Science</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Hepatopulmonary syndrome (HPS) is a respiratory complication of hepatic disease, that is
well recognized in humans and defined by the presence of 1) liver disease, 2) hypoxemia
and/or high alveolar-arterial oxygen gradient (AaDO<sub>2</sub>) and 3) intrapulmonary
vasodilatation. The present report describes a similar case of HPS in a dog. A
six-month-old Papillon was diagnosed with ductal plate malformation with chronic active
hepatitis and showed progressive increases in AaDO<sub>2</sub> over the course of the
following six months. The presence of intrapulmonary vasodilatation was confirmed by
agitated saline contrast transthoracic echocardiography. Also, the absence of congenital
cardiac defect was confirmed by transthoracic echocardiography. From these results, we
suspected that this dog had HPS. This is the first description of suspected canine
HPS.</p>
      </abstract>
      <kwd-group>
        <kwd>agitated saline contrast transthoracic echocardiography</kwd>
        <kwd>canine</kwd>
        <kwd>ductal plate malformation</kwd>
        <kwd>hepatopulmonary syndrome</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Hepatopulmonary syndrome (HPS) is a serious pulmonary vascular complication of liver disease
in humans [<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r24" ref-type="bibr">24</xref>]. There is a report indicating that the median survival time was significantly
lower in cirrhotic patients with HPS compared with those without HPS [<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r19" ref-type="bibr">19</xref>]. Diagnosis of HPS is made by
demonstrating a triad of 1) liver disease, 2) hypoxemia and/or high alveolar-arterial oxygen
gradient (AaDO<sub>2</sub>) and 3) intrapulmonary vasodilatation [<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r22" ref-type="bibr">22</xref>, <xref rid="r24" ref-type="bibr">24</xref>]. AaDO<sub>2</sub>, the indicator of gas exchange efficiency, was
calculated based on the partial pressure of arterial oxygen (PaO<sub>2</sub>) and partial
pressure of arterial carbon dioxide (PaCO<sub>2</sub>). Pulmonary microvascular dilatation
results in ventilation-perfusion mismatch and thus hypoxemia and/or high AaDO<sub>2</sub> in
the absence of marked intrinsic cardiopulmonary disease, such as congenital heart disease with
right-to-left shunt [<xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r20" ref-type="bibr">20</xref>]. To the best of our
knowledge, HPS has not been reported in dogs, and this case report describes the first
suspected case of HPS in a dog.</p>
    <p>A six-month-old female intact Papillon, weighing 1.82
kg, was referred to our hospital due to intermittent vomiting, excessive
salivation and staggering with a duration of 2 months. At the referring hospital, hematology
and serum biochemistry revealed decreased glucose (26 mg/d<italic>l</italic>) and increased
fasting ammonia (352 <italic>&#xB5;</italic>g/d<italic>l</italic>) and serum bile acid (201.5
<italic>&#xB5;</italic>M/<italic>l</italic>), but did not point to specific primary causes.
Lethargy, inappetence and vomiting resolved after symptomatic treatment, but ascites developed
10 days before referral.</p>
    <p>At the first presentation (Day 0), abnormal physical examination findings included a body
condition score of 2/5, moderate dehydration and abdominal distention. The dog&#x2019;s body
temperature was 38.5&#xB0;C, heart rate was 148 beats per min, and respiratory rate was 40 breaths
per min (bpm). Heart and lung sounds were normal. At the referring hospital, the patient had
been subjected to blood tests 1 week previously (Day &#x2212;7). Therefore, the dog was subjected to
minimal blood tests on Day 0 (<xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Results of blood tests on Day &#x2212;7 and Day 0</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">Day 0</th><th valign="bottom" align="center" rowspan="1" colspan="1">Reference range</th><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">Day &#x2212;7</th><th valign="bottom" align="center" rowspan="1" colspan="1">Day 0</th><th valign="bottom" align="center" rowspan="1" colspan="1">Reference range</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">RBC (&#xD7;10<sup>6</sup>/<italic>&#xB5;l</italic>)</td><td align="center" rowspan="1" colspan="1">5.1</td><td align="left" rowspan="1" colspan="1">5.5&#x2013;8.5</td><td align="center" rowspan="1" colspan="1">BUN (mg/d<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">9.2&#x2013;29.2</td></tr><tr><td align="center" rowspan="1" colspan="1">PCV (%)</td><td align="center" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">37&#x2013;55</td><td align="center" rowspan="1" colspan="1">Cre (mg/d<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">0.4&#x2013;1.4</td></tr><tr><td align="center" rowspan="1" colspan="1">Hb (g/d<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">9.5</td><td align="left" rowspan="1" colspan="1">12&#x2013;18</td><td align="center" rowspan="1" colspan="1">AST (U/<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">85</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">17&#x2013;44</td></tr><tr><td align="center" rowspan="1" colspan="1">MCV (f<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">59.6</td><td align="left" rowspan="1" colspan="1">60&#x2013;77</td><td align="center" rowspan="1" colspan="1">ALT (U/<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">17&#x2013;78</td></tr><tr><td align="center" rowspan="1" colspan="1">MCHC (%)</td><td align="center" rowspan="1" colspan="1">31.5</td><td align="left" rowspan="1" colspan="1">32&#x2013;36</td><td align="center" rowspan="1" colspan="1">ALP (U/<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">2,187</td><td align="center" rowspan="1" colspan="1">2,130</td><td align="left" rowspan="1" colspan="1">47&#x2013;254</td></tr><tr><td align="center" rowspan="1" colspan="1">Plate (&#xD7;10<sup>3</sup>/<italic>&#xB5;l</italic>)</td><td align="center" rowspan="1" colspan="1">476</td><td align="left" rowspan="1" colspan="1">200&#x2013;500</td><td align="center" rowspan="1" colspan="1">&#x3B3;-GTP (U/<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">11.6</td><td align="center" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">5&#x2013;14</td></tr><tr><td align="center" rowspan="1" colspan="1">WBC (/<italic>&#xB5;l</italic>)</td><td align="center" rowspan="1" colspan="1">32,700</td><td align="left" rowspan="1" colspan="1">6,000&#x2013;17,000</td><td align="center" rowspan="1" colspan="1">TP (g/d<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">4.1</td><td align="center" rowspan="1" colspan="1">4.2</td><td align="left" rowspan="1" colspan="1">5.0&#x2013;7.2</td></tr><tr><td align="center" rowspan="1" colspan="1">Neutrophil (<italic>/&#xB5;l</italic>)</td><td align="center" rowspan="1" colspan="1">2,587</td><td align="left" rowspan="1" colspan="1">3,000&#x2013;11,500</td><td align="center" rowspan="1" colspan="1">ALB (g/d<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">1.4</td><td align="center" rowspan="1" colspan="1">1.8</td><td align="left" rowspan="1" colspan="1">2.6&#x2013;4.0</td></tr><tr><td align="center" rowspan="1" colspan="1">Lymphocyte (/<italic>&#xB5;l</italic>)</td><td align="center" rowspan="1" colspan="1">7,521</td><td align="left" rowspan="1" colspan="1">1,000&#x2013;4,800</td><td align="center" rowspan="1" colspan="1">GLU (mg/d<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">58</td><td align="left" rowspan="1" colspan="1">75&#x2013;128</td></tr><tr><td align="center" rowspan="1" colspan="1">Monocyte (/<italic>&#xB5;l</italic>)</td><td align="center" rowspan="1" colspan="1">981</td><td align="left" rowspan="1" colspan="1">150&#x2013;1,350</td><td align="center" rowspan="1" colspan="1">NH<sub>3</sub> (<italic>&#xB5;</italic>g/d<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">203</td><td align="left" rowspan="1" colspan="1">16&#x2013;75</td></tr><tr><td align="center" rowspan="1" colspan="1">Eosinophil (/<italic>&#xB5;l</italic>)</td><td align="center" rowspan="1" colspan="1">327</td><td align="left" rowspan="1" colspan="1">100&#x2013;1,250</td><td align="center" rowspan="1" colspan="1">T-CHO (mg/d<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">98</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">111&#x2013;312</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">TG (mg/d<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">30&#x2013;133</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">T-Bil (mg/d<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">0.1</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">0.1&#x2013;0.5</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">CRP (mg/d<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">3.4</td><td align="center" rowspan="1" colspan="1">&#x2264;1.0</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">SBA (<italic>&#xB5;</italic>Ml/<italic>l</italic>)</td><td align="center" rowspan="1" colspan="1">55.9</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">&#x2264;25.0</td></tr></tbody></table><table-wrap-foot><p>RBC: red blood cell, PCV: packed cell volume, Hb: hemoglobin, MCV: mean corpuscular
volume, MCHC: mean corpuscular hemoglobin concentration, WBC: white blood cell, BUN:
blood urea nitrogen, Cre: creatine, AST: aspartate aminotransferase, ALT: alanine
aminotransferase, ALP: alkaline phosphatase, &#x3B3;-GTP: gamma-glutamyl transpeptidase, TP:
total protein, ALB: albumin, GLU: glucose, NH: ammonia, T-CHO: total cholesterol, TG:
triglyceride, T-Bil: total bilirubin, CRP: C-reactive protein, SBA: serum bile acid, -,
No data.</p></table-wrap-foot></table-wrap>). On Day 0, complete blood cell count (CBC) abnormalities included an elevated
white blood cell count and mild anemia. Abnormal biochemical values included increases in
ammonia, alkaline phosphatase, gamma glutamyl transferase and C-reactive protein as well as
decreases in total protein, albumin, glucose and total cholesterol (<xref rid="tbl_001" ref-type="table">Table 1</xref>). The dog was not icteric, and the coagulation profile
(prothrombin time, activated partial thromboplastin time and fibrinogen) was normal. Abdominal
ultrasonography revealed ascites, microhepatia (<xref ref-type="fig" rid="fig_001">Fig.
1</xref><fig orientation="portrait" fig-type="figure" id="fig_001" position="float"><label>Fig. 1.</label><caption><p>Ultrasonograph of the liver in the dog with ductal plate malformation. Ascites and
microhepatia in the left lateral (LLL) and left medial lobes (LML) were noted. The
intrahepatic portal vein was not clearly identified.</p></caption><graphic xlink:href="jvms-78-493-g001"/></fig>) and mobile biliary sludge in the gallbladder. No abnormalities were found in the other
abdominal organs. Ascites was a pure transudate with low protein (0.7 mg/d<italic>l</italic>),
a low specific gravity (1.005) and low nucleated cell counts (400 cells/<italic>&#xB5;l</italic>).
Based on these findings and signs, ductal plate malformation and portal vein hypoplasia were
suspected.</p>
    <p>Liver biopsy was performed under general anesthesia. The dog was premedicated with a
subcutaneous injection of atropine sulfate (0.04 mg/kg: Atropine sulfate injection, Fuso
Pharmaceutical Industries, Osaka, Japan). Thirty minutes later, fentanyl (10
<italic>&#xB5;g</italic>/kg; Fentanyl Citrate, Janssen Pharmaceutical, Tokyo, Japan) was injected
for sedation, and propofol (approximately 3 mg/kg; Propofol injection, Fuji Pharma, Tokyo,
Japan) was administered for tracheal intubation. Anesthesia was maintained with 0.4&#x2013;1.2%
isoflurane (Isoful, DS Pharma Biomedical, Osaka, Japan) delivered with pure oxygen and
fentanyl delivered as a continuous rate infusion (42 <italic>&#xB5;g</italic>/kg/min). Liver biopsy
was performed with particular attention to hemostasis, as ascites was observed. During the
laparoscopic biopsy procedure, multiple small nodules suggestive of cirrhosis were visually
confirmed in all of the liver lobes (<xref ref-type="fig" rid="fig_002">Fig. 2A</xref><fig orientation="portrait" fig-type="figure" id="fig_002" position="float"><label>Fig. 2.</label><caption><p>Laparoscopic image of the liver (A) and multiple portosystemic shunts (B) in the dog
with ductal plate malformation. All of the liver lobes were small, and small multiple
nodules were visually confirmed (A). Laparoscopy also revealed multiple portosystemic
shunts (arrow) near the caudal vena cava (B). GB: gallbladder; RK: right kidney; CV:
caudal vena cava.</p></caption><graphic xlink:href="jvms-78-493-g002"/></fig>). Laparoscopy also revealed multiple portosystemic shunts near the caudal vena cava
(<xref ref-type="fig" rid="fig_002">Fig. 2B</xref>). Biopsy specimens were obtained from the
left lateral lobe and the quadrate lobe of the liver. The procedure was completed after
confirming hemostasis. The histopathological diagnosis was ductal plate malformation with
chronic active hepatitis (<xref ref-type="fig" rid="fig_003">Fig. 3</xref><fig orientation="portrait" fig-type="figure" id="fig_003" position="float"><label>Fig. 3.</label><caption><p>Photomicrograph of the left lateral lobe of the liver stained with hematoxylin and
eosin. Note the poorly defined lobular structure, extensive proliferation of
medium-sized interlobular bile ducts and lack of the portal structure. Mild-to-moderate
interlobular fibrosis is accompanied by infiltration of numerous lymphocytes, plasma
cells and some neutrophils. Ductal plate malformation with lymphoplasmacytic active
hepatitis was diagnosed. Bar=100 <italic>&#xB5;</italic>m.</p></caption><graphic xlink:href="jvms-78-493-g003"/></fig>).</p>
    <p>Until the histopathological diagnosis, the dog was placed on symptomatic therapy with 0.5
m<italic>l</italic>/kg lactulose (Piarle Syrup 65%; Takata Pharmaceutical, Tokyo, Japan)
orally twice a day, 1 mg/kg furosemide (Furosemide; Teva Pharmaceutical, Tokyo, Japan) orally
twice a day, 1 mg/kg spironolactone (Spironolactone; Nichi-Iko Pharmaceutical, Toyama, Japan)
orally twice a day, 5 mg/kg polaprezinc (Promac granules 15%; Zeria Pharmaceutical, Tokyo,
Japan) orally twice a day, 0.2 g/animal of branched-chain amino acids product (Livact
granules; Ajinomoto Pharmaceuticals, Tokyo, Japan) orally twice a day and 0.5 g/animal of a
liver support supplement (Vegetable Support Doctor Plus; W.I. System, Tokyo, Japan) orally
twice a day. Based on the histopathological diagnosis, tapering doses of prednisolone
(Prednisolone; Takeda Pharmaceutical, Osaka, Japan) were added to the regimen (1 mg/kg orally
twice a day for 3 days, 1 mg/kg orally once a day for 1 week, 0.5 mg/kg orally once a day for
2 weeks and then 0.5 mg/kg orally every other day). Regular follow-up evaluations were
scheduled.</p>
    <p>We have previously encountered poor respiratory conditions in patients with hepatic disease.
In particular, dogs with chronic hepatitis showed significantly lower PaO<sub>2</sub> and
higher AaDO<sub>2</sub> than dogs in the control group [<xref rid="r9" ref-type="bibr">9</xref>]. The present case did not show serious respiratory signs; however, the
respiratory rate increased slightly. Therefore, arterial blood gas analysis was performed
regularly. Arterial blood samples were obtained in room air. The dog was placed and rested in
lateral recumbency, and blood was drawn from the femoral artery using a 25-gauge needle and a
heparinized 1-m<italic>l</italic> syringe (a small amount of heparin sodium was drawn into the
syringe to wet the entire syringe and expelled to the fullest extent possible). Arterial blood
gas analysis (i-STAT 300F analyzer, Fuso Pharmaceutical Industries, Osaka, Japan, with i-STAT
CG4+ cartridges, Abbott Laboratories, Abbott Park, IL, U.S.A.) was performed within one min
after sample collection. On Day 29, the dog&#x2019;s respiratory rate was 40 bpm. PaO<sub>2</sub>
(reference ranges, 80 to 100 mmHg), PaCO<sub>2</sub> (reference range, 35 to 45 mmHg) and
AaDO<sub>2</sub> (reference range, &#x2264;15 mmHg) were 93 mmHg, 28.8 mmHg and 20.7 mmHg,
respectively. On Day 168, the dog was panting. Increased AaDO<sub>2</sub> was noted (30.4
mmHg) with a PaO<sub>2</sub> and PaCO<sub>2</sub> of 89 and 24.3 mmHg, respectively. Although
thoracic radiographs did not show any abnormalities, increased AaDO<sub>2</sub> indicated
possible ventilation-perfusion imbalance, right-to-left shunting or diffusion impairment. On
Day 174, the dog&#x2019;s respiratory rate was 52 bpm. AaDO<sub>2</sub> was still high (28.9 mmHg)
with a PaO<sub>2</sub> of 85 mmHg and PaCO<sub>2</sub> of 28.7 mmHg (<xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Results of arterial blood gas analysis on Day 29, Day 168 and Day 174</title></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="left" rowspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">Day 29</th><th valign="bottom" align="center" rowspan="1" colspan="1">Day 168</th><th valign="bottom" align="center" rowspan="1" colspan="1">Day 174</th><th valign="bottom" align="center" rowspan="1" colspan="1">Reference range</th></tr></thead><tbody><tr><td align="right" rowspan="1" colspan="1">PaO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">(mmHg)</td><td align="center" valign="bottom" rowspan="1" colspan="1">93</td><td align="center" valign="bottom" rowspan="1" colspan="1">89</td><td align="center" valign="bottom" rowspan="1" colspan="1">85</td><td align="center" rowspan="1" colspan="1">80&#x2013;105</td></tr><tr><td align="right" rowspan="1" colspan="1">PaCO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">(mmHg)</td><td align="center" valign="bottom" rowspan="1" colspan="1">28.8</td><td align="center" valign="bottom" rowspan="1" colspan="1">24.3</td><td align="center" valign="bottom" rowspan="1" colspan="1">28.7</td><td align="center" rowspan="1" colspan="1">35.0&#x2013;45.0</td></tr><tr><td align="right" rowspan="1" colspan="1">AaDO<sub>2</sub></td><td align="left" rowspan="1" colspan="1">(mmHg)</td><td align="center" valign="bottom" rowspan="1" colspan="1">20.7</td><td align="center" valign="bottom" rowspan="1" colspan="1">30.4</td><td align="center" valign="bottom" rowspan="1" colspan="1">28.9</td><td align="center" rowspan="1" colspan="1">&#x2264;15.0</td></tr></tbody></table><table-wrap-foot><p>PaO<sub>2</sub>: partial pressure of arterial oxygen, PaCO<sub>2</sub>: partial
pressure of arterial carbon dioxide, AaDO2: alveolar-arterial oxygen gradient.</p></table-wrap-foot></table-wrap>).</p>
    <p>At this point, we suspected HPS, as the patient satisfied the first two criteria (liver
disease and high AaDO<sub>2</sub>) and AaDO<sub>2</sub> had gradually increased. Therefore, we
performed agitated saline contrast transthoracic echocardiography (ASC-TTE) to examine
intrapulmonary vasodilatation. Routine echocardiography revealed mild mitral regurgitation but
ruled out the presence of septal defect or other form of congenital heart malformation. For
ASC-TTE, 2 m<italic>l</italic> of saline were mixed with 0.2 m<italic>l</italic> of the
patient&#x2019;s blood and air, agitated to generate bubbles and injected into a cephalic vein as a
bolus. The bubbles made with agitated saline were detected in the right heart immediately
after injection and then in the left heart after the 5th heartbeat (<xref ref-type="fig" rid="fig_004">Fig. 4</xref><fig orientation="portrait" fig-type="figure" id="fig_004" position="float"><label>Fig. 4.</label><caption><p>Agitated saline contrast transthoracic echocardiography (ASC-TTE) for detection of
microbubbles in the left atrium (LA) and ventricle (LV) after intravascular injection in
a dog. For ASC-TTE, 2 m<italic>l</italic> of 0.9% saline were mixed with 0.2
m<italic>l</italic> of blood and air, agitated to generate bubbles and injected into a
cephalic vein as a bolus. The bubbles were detected in the right heart immediately after
intravascular injection and then in the left heart after the 5th heartbeat, which is
indicative of intrapulmonary vasodilatation. (A) Four-chamber view before injection of
saline microbubbles. (B) Microbubbles in the right atrium (RA) and ventricle (RV)
immediately after injection of the contrast agent. (C) Microbubbles (arrows) in the LA
and LV captured at the 21st heartbeat. (The bubbles started to appear after the 5th
heartbeat, however, it is difficult to identify the bubbles in a picture. Therefore, a
picture of the 21st heartbeat is used in this figure.)</p></caption><graphic xlink:href="jvms-78-493-g004"/></fig>) (<xref ref-type="supplementary-material" rid="mp4_001">Supplementary movie</xref>), which is indicative of intrapulmonary vasodilatation. From
these results, HPS was strongly suspected, as the dog met all three criteria for HPS. The dog
was managed with the same drug regimen and close monitoring. On Day 287, similar results were
obtained by ASC-TTE, but the dog&#x2019;s condition was generally favorable with a relatively stable
respiratory rate (24 bpm), although hyperammonemia (235
<italic>&#xB5;</italic>M/<italic>l</italic>) and elevated liver enzymes persisted.</p>
    <p>First reported in 1966 [<xref rid="r5" ref-type="bibr">5</xref>], HPS is a well-recognized
liver-induced vascular disorder of the lung in humans [<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r24" ref-type="bibr">24</xref>]. It is more frequently associated with
chronic forms of liver disease, occurring in 10 to 30% of cirrhotic patients [<xref rid="r8" ref-type="bibr">8</xref>], and known to markedly increase the mortality rate [<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r19" ref-type="bibr">19</xref>]. Currently,
liver transplantation is the only option for treatment [<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r22" ref-type="bibr">22</xref>, <xref rid="r24" ref-type="bibr">24</xref>] and is recommended at the earliest possible timing [<xref rid="r14" ref-type="bibr">14</xref>]. Although the exact pathophysiological mechanism of HPS is not
understood, it appears that intrapulmonary vasodilatation and/or a pulmonary arteriovenous
fistula leads to ventilation-perfusion mismatch, resulting in impaired arterial oxygenation
[<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r22" ref-type="bibr">22</xref>, <xref rid="r24" ref-type="bibr">24</xref>]. Dilatation of pulmonary microvessels at the gas
exchange interface increases the distance that oxygen must travel from the alveolus to
equilibrate with red blood cells in the center of the alveolar capillary. This causes a
functional diffusional barrier to oxygen exchange [<xref rid="r2" ref-type="bibr">2</xref>,
<xref rid="r10" ref-type="bibr">10</xref>]. In addition, HPS patients with cirrhosis have
been reported to have hyperdynamic circulation [<xref rid="r13" ref-type="bibr">13</xref>].
Therefore, this diffusional barrier is exacerbated by rapid blood transit, as
alveolar-capillary equilibration for oxygen is influenced by the blood transit time [<xref rid="r10" ref-type="bibr">10</xref>]. Also, the pulmonary gas exchange abnormalities of HPS
are characterized by hyperventilation [<xref rid="r24" ref-type="bibr">24</xref>]. Therefore,
dilation of micro-vessels allows PaO<sub>2</sub> and PaCO<sub>2</sub> to decrease.
AaDO<sub>2</sub> was calculated based on PaO<sub>2</sub> and PaCO<sub>2</sub> with the a
fraction of inspiratory oxygen (FiO<sub>2</sub>) of 0.21 (for room air), barometric pressure
(P<sub>B</sub>) of 765 mmHg, water vapor pressure (P<sub>H2O</sub>) of 50 mmHg and
respiratory exchange ratio (R) of 0.8 using the following formula:
AaDO<sub>2</sub>=[FiO<sub>2</sub> &#xD7; (P<sub>B</sub> &#x2212; P<sub>H2O</sub>) &#x2212; PaCO<sub>2</sub>/R]
&#x2212; PaO<sub>2</sub>. Therefore, AaDO<sub>2</sub> increases in HPS with intrapulmonary
vasodilatation [<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r24" ref-type="bibr">24</xref>]. Patients may also have true anatomical shunting in the form of direct
arteriovenous communications, which allow blood to completely bypass alveoli, resulting in
mixed venous blood passing into the pulmonary veins [<xref rid="r8" ref-type="bibr">8</xref>].</p>
    <p>The diagnosis of HPS requires demonstration of the triad of liver disease, abnormal arterial
blood gases and intrapulmonary vasodilatation. ASC-TTE is a simple and highly sensitive
diagnostic procedure for the detection of intrapulmonary vasodilatation [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r21" ref-type="bibr">21</xref>]. When a small amount of saline solution, blood and air are agitated and
intravenously injected, the bubbles they form are initially detected in the right heart and
then move to the pulmonary vascular bed, but they cannot pass the pulmonary capillary
circulation because they are larger (&#x2265;15 <italic>&#xB5;</italic>m) than the diameter of the
capillaries (5 to 8 <italic>&#xB5;</italic>m in humans and 6.5 <italic>&#xB5;</italic>m in dogs) [<xref rid="r7" ref-type="bibr">7</xref>]. Generally, bubbles are not observed in the left heart in
dogs [<xref rid="r12" ref-type="bibr">12</xref>]. Thus, immediate detection of bubbles in the
left heart indicates congenital malformation in the heart, such as an atrial septal defect or
ventricular septal defect [<xref rid="r22" ref-type="bibr">22</xref>, <xref rid="r24" ref-type="bibr">24</xref>]. In dogs, this technology has been used to demonstrate right-to-left
shunting [<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r23" ref-type="bibr">23</xref>],
but not to demonstrate intrapulmonary vasodilatation. On the other hand, as demonstrated in
the present case, if bubbles appear in the left heart about 4 to 6 heartbeats after
visualization in the right heart [<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r21" ref-type="bibr">21</xref>], it suggests
the presence of intrapulmonary vasodilatation. The present report also demonstrated the
usefulness of ASC-TTE for the diagnosis of pulmonary vasodilatation in dogs.</p>
    <p>In this case, 1) liver disease (ductal plate malformation with chronic active hepatitis), 2)
high AaDO<sub>2</sub> without hypoxemia and 3) intrapulmonary vasodilation, as shown by
ASC-TTE, were present. Therefore, HPS was strongly suspected, as the dog met all three
criteria for. Human HPS patients often report shortness of breath during normal exercise. In
this case report, the respiratory rate was slightly increased, but respiratory signs were not
observed. Hypoxemia (PaO<sub>2</sub>&lt;80 mmHg) was not observed as well. Thus, it is
considered that this case would be classified as mild HPS in humans [<xref rid="r15" ref-type="bibr">15</xref>]. However, there is a report that the median survival time was
significantly lower in cirrhotic patients with HPS compared with those without HPS [<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r19" ref-type="bibr">19</xref>]. Therefore,
detection of gas exchange abnormalities, even if they are mild abnormalities (increased
AaDO<sub>2</sub>, PaO<sub>2</sub>&gt;80 mmHg), and diagnose of HPS are important [<xref rid="r24" ref-type="bibr">24</xref>]. There are no reports of dogs with HPS yet. It is
unclear whether the prognosis evaluation for human could be applied to dogs. However, HPS is
typically a progressive pathophysiology [<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r17" ref-type="bibr">17</xref>, <xref rid="r20" ref-type="bibr">20</xref>]. Therefore,
dogs with HPS should be closely monitored for respiratory condition.</p>
    <p>This is the first report of suspected canine HPS. The present case fulfilled the definitive
diagnosis requirements for HPS in humans, but it is considered necessary to perform autopsy in
the future. The prevalence of HPS is reported to be from 10 to 30% in human patients with
liver cirrhosis [<xref rid="r8" ref-type="bibr">8</xref>]. It is possible that dogs with liver
disease, especially chronic hepatitis and liver cirrhosis, more or less experience
deterioration in gas exchange. Therefore, clinical veterinarians will need to recognize the
presence of the disease.</p>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="mp4_001">
        <caption>
          <title>Supplementary movie</title>
        </caption>
        <media mimetype="video" mime-subtype="mp4" xlink:href="jvms-78-493-s001.mp4" orientation="portrait" xlink:type="simple" id="d36e1004" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>This work was conducted at the Veterinary Teaching Hospital at the
University of Miyazaki, and no grant support or other funding was received for this study.
The authors thank Dr Mikito Mori, BVSc, at Morinoki Animal Hospital (Kagoshima, Japan) for
case referral.</p>
    </ack>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Abrams</surname><given-names>G. A.</given-names></name><name><surname>Jaffe</surname><given-names>C. C.</given-names></name><name><surname>Hoffer</surname><given-names>P. B.</given-names></name><name><surname>Binder</surname><given-names>H. J.</given-names></name><name><surname>Fallon</surname><given-names>M. B.</given-names></name></person-group><year>1995</year>. <article-title>Diagnostic utility of contrast
echocardiography and lung perfusion scan in patients with hepatopulmonary
syndrome</article-title>.
<source><italic>Gastroenterology</italic></source><volume>109</volume>:
<fpage>1283</fpage>&#x2013;<lpage>1288</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0016-5085(95)90589-8</pub-id><pub-id pub-id-type="pmid">7557096</pub-id></mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Agusti</surname><given-names>A. G.</given-names></name><name><surname>Roca</surname><given-names>J.</given-names></name><name><surname>Rodriguez-Roisin</surname><given-names>R.</given-names></name></person-group><year>1996</year>. <article-title>Mechanisms of gas exchange impairment in
patients with liver cirrhosis</article-title>. <source><italic>Clin. Chest
Med.</italic></source><volume>17</volume>: <fpage>49</fpage>&#x2013;<lpage>66</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/S0272-5231(05)70298-7</pub-id><pub-id pub-id-type="pmid">8665790</pub-id></mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Aller</surname><given-names>R.</given-names></name><name><surname>Moya</surname><given-names>J. L.</given-names></name><name><surname>Moreira</surname><given-names>V.</given-names></name><name><surname>Boixeda</surname><given-names>D.</given-names></name><name><surname>Cano</surname><given-names>A.</given-names></name><name><surname>Picher</surname><given-names>J.</given-names></name><name><surname>Garcia-Rull</surname><given-names>S.</given-names></name><name><surname>De Luis</surname><given-names>D. A.</given-names></name></person-group><year>1999</year>. <article-title>Diagnosis of hepatopulmonary syndrome
with contrast transesophageal echocardiography: advantages over contrast transthoracic
echocardiography</article-title>. <source><italic>Dig. Dis.
Sci.</italic></source><volume>44</volume>: <fpage>1243</fpage>&#x2013;<lpage>1248</lpage>. doi:
<pub-id pub-id-type="doi">10.1023/A:1026657114256</pub-id><pub-id pub-id-type="pmid">10389704</pub-id></mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Arndt</surname><given-names>J. W.</given-names></name><name><surname>Oyama</surname><given-names>M. A.</given-names></name></person-group><year>2008</year>. <article-title>Agitated saline contrast echocardiography
to diagnose a congenital heart defect in a dog</article-title>. <source><italic>J. Vet.
Cardiol.</italic></source><volume>10</volume>: <fpage>129</fpage>&#x2013;<lpage>132</lpage>.
doi: <pub-id pub-id-type="doi">10.1016/j.jvc.2008.03.004</pub-id><pub-id pub-id-type="pmid">19010756</pub-id></mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Berthelot</surname><given-names>P.</given-names></name><name><surname>Walker</surname><given-names>J. G.</given-names></name><name><surname>Sherlock</surname><given-names>S.</given-names></name><name><surname>Reid</surname><given-names>L.</given-names></name></person-group><year>1966</year>. <article-title>Arterial changes in the lungs in
cirrhosis of the liver-lung spider nevi</article-title>. <source><italic>N. Engl. J.
Med.</italic></source><volume>274</volume>: <fpage>291</fpage>&#x2013;<lpage>298</lpage>.
doi: <pub-id pub-id-type="doi">10.1056/NEJM196602102740601</pub-id><pub-id pub-id-type="pmid">5903210</pub-id></mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Fallon</surname><given-names>M. B.</given-names></name><name><surname>Krowka</surname><given-names>M. J.</given-names></name><name><surname>Brown</surname><given-names>R. S.</given-names></name><name><surname>Trotter</surname><given-names>J. F.</given-names></name><name><surname>Zacks</surname><given-names>S.</given-names></name><name><surname>Roberts</surname><given-names>K. E.</given-names></name><name><surname>Shah</surname><given-names>V. H.</given-names></name><name><surname>Kaplowitz</surname><given-names>N.</given-names></name><name><surname>Forman</surname><given-names>L.</given-names></name><name><surname>Wille</surname><given-names>K.</given-names></name><name><surname>Kawut</surname><given-names>S. M.</given-names></name></person-group><year>2008</year>. <article-title>Impact of hepatopulmonary syndrome on
quality of life and survival in liver transplant candidates</article-title>.
<source><italic>Gastroenterology</italic></source><volume>135</volume>:
<fpage>1168</fpage>&#x2013;<lpage>1175</lpage>. doi: <pub-id pub-id-type="doi">10.1053/j.gastro.2008.06.038</pub-id><pub-id pub-id-type="pmid">18644373</pub-id></mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Glazier</surname><given-names>J. B.</given-names></name><name><surname>Hughes</surname><given-names>J. M.</given-names></name><name><surname>Maloney</surname><given-names>J. E.</given-names></name><name><surname>West</surname><given-names>J. B.</given-names></name></person-group><year>1969</year>. <article-title>Measurements of capillary dimensions and
blood volume in rapidly frozen lungs</article-title>. <source><italic>J. Appl.
Physiol.</italic></source><volume>26</volume>: <fpage>65</fpage>&#x2013;<lpage>76</lpage>.
<pub-id pub-id-type="pmid">5762878</pub-id></mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Grace</surname><given-names>J. A.</given-names></name><name><surname>Angus</surname><given-names>P. W.</given-names></name></person-group><year>2013</year>. <article-title>Hepatopulmonary syndrome: update on
recent advances in pathophysiology, investigation, and treatment</article-title>.
<source><italic>J. Gastroenterol. Hepatol.</italic></source><volume>28</volume>:
<fpage>213</fpage>&#x2013;<lpage>219</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jgh.12061</pub-id><pub-id pub-id-type="pmid">23190201</pub-id></mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Kaneko</surname><given-names>Y.</given-names></name><name><surname>Torisu</surname><given-names>S.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Mizutani</surname><given-names>S.</given-names></name><name><surname>Tsuzuki</surname><given-names>N.</given-names></name><name><surname>Sonoda</surname><given-names>H.</given-names></name><name><surname>Ikeda</surname><given-names>M.</given-names></name><name><surname>Naganobu</surname><given-names>K.</given-names></name></person-group><year>2015</year>. <article-title>Arterial blood gas anomaly in canine
hepatobiliary disease</article-title>. <source><italic>J. Vet. Med.
Sci.</italic></source><comment>[Epub ahead of print]</comment>. doi: <pub-id pub-id-type="doi">10.1292/jvms.15-0169</pub-id><pub-id pub-id-type="pmid">26256228</pub-id></mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Katsuta</surname><given-names>Y.</given-names></name><name><surname>Honma</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>X. J.</given-names></name><name><surname>Ohsuga</surname><given-names>M.</given-names></name><name><surname>Komeichi</surname><given-names>H.</given-names></name><name><surname>Shimizu</surname><given-names>S.</given-names></name><name><surname>Katoh</surname><given-names>Y.</given-names></name><name><surname>Miura</surname><given-names>H.</given-names></name><name><surname>Satomura</surname><given-names>K.</given-names></name><name><surname>Aramaki</surname><given-names>T.</given-names></name><name><surname>Takano</surname><given-names>T.</given-names></name></person-group><year>2005</year>. <article-title>Pulmonary blood transit time and impaired
arterial oxygenation in patients with chronic liver disease</article-title>.
<source><italic>J. Gastroenterol.</italic></source><volume>40</volume>:
<fpage>57</fpage>&#x2013;<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00535-004-1495-6</pub-id><pub-id pub-id-type="pmid">15692790</pub-id></mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Krowka</surname><given-names>M. J.</given-names></name><name><surname>Dickson</surname><given-names>E. R.</given-names></name><name><surname>Cortese</surname><given-names>D. A.</given-names></name></person-group><year>1993</year>. <article-title>Hepatopulmonary syndrome. Clinical
observations and lack of therapeutic response to somatostatin analogue</article-title>.
<source><italic>Chest</italic></source><volume>104</volume>:
<fpage>515</fpage>&#x2013;<lpage>521</lpage>. doi: <pub-id pub-id-type="doi">10.1378/chest.104.2.515</pub-id><pub-id pub-id-type="pmid">8101797</pub-id></mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Hagio</surname><given-names>M.</given-names></name></person-group><year>1989</year> Ultrasound diagnosis of heart and chest disease. pp.
9&#x2013;52. <italic>In</italic>: Chouonpa Gazou Shindan (Ultrasound imaging) (Too, K ed.),
Gakusousha, Tokyo (in Japanese).</mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>M&#xF8;ller</surname><given-names>S.</given-names></name><name><surname>Krag</surname><given-names>A.</given-names></name><name><surname>Henriksen</surname><given-names>J. H.</given-names></name><name><surname>Bendtsen</surname><given-names>F.</given-names></name></person-group><year>2007</year>. <article-title>Pathophysiological aspects of pulmonary
complications of cirrhosis</article-title>. <source><italic>Scand. J.
Gastroenterol.</italic></source><volume>42</volume>:
<fpage>419</fpage>&#x2013;<lpage>427</lpage>. doi: <pub-id pub-id-type="doi">10.1080/00365520601151695</pub-id><pub-id pub-id-type="pmid">17454850</pub-id></mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Murray</surname><given-names>K. F.</given-names></name><name><surname>Carithers</surname><given-names>R. L.</given-names><suffix>Jr</suffix></name></person-group><year>2005</year>. <article-title>AASLD practice guidelines: evaluation of
the patient for liver transplantation</article-title>.
<source><italic>Hepatology</italic></source><volume>41</volume>:
<fpage>1407</fpage>&#x2013;<lpage>1432</lpage>. doi: <pub-id pub-id-type="doi">10.1002/hep.20704</pub-id><pub-id pub-id-type="pmid">15880505</pub-id></mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Raevens</surname><given-names>S.</given-names></name><name><surname>Geerts</surname><given-names>A.</given-names></name><name><surname>Van</surname><given-names>S. C.</given-names></name><name><surname>Verhelst</surname><given-names>X.</given-names></name><name><surname>Van</surname><given-names>V. H.</given-names></name><name><surname>Colle</surname><given-names>I.</given-names></name></person-group><year>2015</year>. <article-title>Hepatopulmonary syndrome and
portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical
assessment</article-title>. <source><italic>Liver
Int.</italic></source><volume>35</volume>: <fpage>1646</fpage>&#x2013;<lpage>1660</lpage>. doi:
<pub-id pub-id-type="doi">10.1111/liv.12791</pub-id><pub-id pub-id-type="pmid">25627425</pub-id></mixed-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Rodr&#xED;guez-Roisin</surname><given-names>R.</given-names></name><name><surname>Krowka</surname><given-names>M. J.</given-names></name></person-group><year>2008</year>. <article-title>Hepatopulmonary syndrome&#x2013;a liver-induced
lung vascular disorder</article-title>. <source><italic>N. Engl. J.
Med.</italic></source><volume>358</volume>: <fpage>2378</fpage>&#x2013;<lpage>2387</lpage>.
doi: <pub-id pub-id-type="doi">10.1056/NEJMra0707185</pub-id><pub-id pub-id-type="pmid">18509123</pub-id></mixed-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Saunders</surname><given-names>K. B.</given-names></name><name><surname>Fernando</surname><given-names>S. S.</given-names></name><name><surname>Dalton</surname><given-names>H. R.</given-names></name><name><surname>Joseph</surname><given-names>A.</given-names></name></person-group><year>1994</year>. <article-title>Spontaneous improvement in a patient with
the hepatopulmonary syndrome assessed by serial exercise tests</article-title>.
<source><italic>Thorax</italic></source><volume>49</volume>:
<fpage>725</fpage>&#x2013;<lpage>727</lpage>. doi: <pub-id pub-id-type="doi">10.1136/thx.49.7.725</pub-id><pub-id pub-id-type="pmid">8066574</pub-id></mixed-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Schenk</surname><given-names>P.</given-names></name><name><surname>Fuhrmann</surname><given-names>V.</given-names></name><name><surname>Madl</surname><given-names>C.</given-names></name><name><surname>Funk</surname><given-names>G.</given-names></name><name><surname>Lehr</surname><given-names>S.</given-names></name><name><surname>Kandei</surname><given-names>O.</given-names></name><name><surname>M&#xFC;ller</surname><given-names>C.</given-names></name></person-group><year>2002</year>. <article-title>Hepatopulmonary syndrome: prevalence and
predictive value of various cut offs for arterial oxygenation and their clinical
consequences</article-title>. <source><italic>Gut</italic></source><volume>51</volume>:
<fpage>853</fpage>&#x2013;<lpage>859</lpage>. doi: <pub-id pub-id-type="doi">10.1136/gut.51.6.853</pub-id><pub-id pub-id-type="pmid">12427789</pub-id></mixed-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Schenk</surname><given-names>P.</given-names></name><name><surname>Sch&#xF6;niger-Hekele</surname><given-names>M.</given-names></name><name><surname>Fuhrmann</surname><given-names>V.</given-names></name><name><surname>Madl</surname><given-names>C.</given-names></name><name><surname>Silberhumer</surname><given-names>G.</given-names></name><name><surname>M&#xFC;ller</surname><given-names>C.</given-names></name></person-group><year>2003</year>. <article-title>Prognostic significance of the
hepatopulmonary syndrome in patients with cirrhosis</article-title>.
<source><italic>Gastroenterology</italic></source><volume>125</volume>:
<fpage>1042</fpage>&#x2013;<lpage>1052</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0016-5085(03)01207-1</pub-id><pub-id pub-id-type="pmid">14517788</pub-id></mixed-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Swanson</surname><given-names>K. L.</given-names></name><name><surname>Wiesner</surname><given-names>R. H.</given-names></name><name><surname>Krowka</surname><given-names>M. J.</given-names></name></person-group><year>2005</year>. <article-title>Natural history of hepatopulmonary
syndrome: impact of liver transplantation</article-title>.
<source><italic>Hepatology</italic></source><volume>41</volume>:
<fpage>1122</fpage>&#x2013;<lpage>1129</lpage>. doi: <pub-id pub-id-type="doi">10.1002/hep.20658</pub-id><pub-id pub-id-type="pmid">15828054</pub-id></mixed-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Vedrinne</surname><given-names>J. M.</given-names></name><name><surname>Duperret</surname><given-names>S.</given-names></name><name><surname>Bizollon</surname><given-names>T.</given-names></name><name><surname>Magnin</surname><given-names>C.</given-names></name><name><surname>Motin</surname><given-names>J.</given-names></name><name><surname>Trepo</surname><given-names>C.</given-names></name><name><surname>Ducerf</surname><given-names>C.</given-names></name></person-group><year>1997</year>. <article-title>Comparison of transesophageal and
transthoracic contrast echocardiography for detection of an intrapulmonary shunt in
liver disease</article-title>.
<source><italic>Chest</italic></source><volume>111</volume>:
<fpage>1236</fpage>&#x2013;<lpage>1240</lpage>. doi: <pub-id pub-id-type="doi">10.1378/chest.111.5.1236</pub-id><pub-id pub-id-type="pmid">9149575</pub-id></mixed-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Wang</surname><given-names>Y. W.</given-names></name><name><surname>Lin</surname><given-names>H. C.</given-names></name></person-group><year>2005</year>. <article-title>Recent advances in hepatopulmonary
syndrome</article-title>. <source><italic>J. Chin. Med.
Assoc.</italic></source><volume>68</volume>: <fpage>500</fpage>&#x2013;<lpage>505</lpage>. doi:
<pub-id pub-id-type="doi">10.1016/S1726-4901(09)70083-8</pub-id><pub-id pub-id-type="pmid">16323392</pub-id></mixed-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <mixed-citation publication-type="book"><person-group><name><surname>Wendy</surname><given-names>A. W.</given-names></name></person-group><year>2009</year> Echocardiography. pp. 33&#x2013;48. <italic>In</italic>: Small
Animal Internal Medicine, 4th ed. (Nelson, R. W. and Couto, C. G. eds.), Elsevier, St.
Louis.</mixed-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Fallon</surname><given-names>M. B.</given-names></name></person-group><year>2012</year>. <article-title>Hepatopulmonary syndrome: update on
pathogenesis and clinical features</article-title>. <source><italic>Nat. Rev.
Gastroenterol. Hepatol.</italic></source><volume>9</volume>:
<fpage>539</fpage>&#x2013;<lpage>549</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrgastro.2012.123</pub-id><pub-id pub-id-type="pmid">22751459</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
